September 2019, Vol. 32(Suppl. 2): 1-79
© 2019 Sociedad Española de Quimioterapia
• Introduction
Update in Infectious Diseases 2019
(Actualización en patología infecciosa 2019)
FRANCISCO JAVIER CANDEL, CARLA MARGARITA RICO, IRENE DÍAZ DE LA TORRE, BERTA LAGUNA, JORGE MARTÍNEZ-JORDÁN, SARA MEDRANO, MAURICIO CÉSAR ESCOBAR-PORCEL, ANGEL LÓPEZ-DELGADO, LAURA LÓPEZ-GONZÁLEZ, JOSE MANUEL VIÑUELA-PRIETO, MAYRA MATESANZ, JUAN GONZÁLEZ DEL CASTILLO, ANA ARRIBI
Rev Esp Quimioter 2019; 32 (Suppl. 2): 1-9.
• Update in infection related meetings 2018
Highlights at the ASM Microbe 2018, Atlanta (USA)
EMILIA CERCENADO
Rev Esp Quimioter 2019; 32 (Suppl. 2): 10-15. [Full-text PDF]
Highlights at the 28th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2018
SANDRA NABAL, SARAY MORMENEO, JUAN M. GARCÍA-LECHUZ
Rev Esp Quimioter 2019; 32 (Suppl. 2): 16-21. [Full-text PDF]
Some impressions of the content of the San Francisco ID-Week, in the area of bacterial infection
EMILIO BOUZA
Rev Esp Quimioter 2019; 32 (Suppl. 2): 22-23. [Full-text PDF]
Highlights from 22nd International AIDS Conference
MARÍA JOSÉ NÚÑEZ-ORANTOS, NOEMÍ CABELLO CLOTET, JORGE VERGAS GARCÍA, MARÍA JESÚS TÉLLEZ MOLINA, VICENTE ESTRADA PÉREZ
Rev Esp Quimioter 2019; 32 (Suppl. 2): 24-26. [Full-text PDF]
• Update in nosocomial infection
Current status of ESKAPE microorganisms in Spain: Epidemiology and resistance phenotypes
JAVIER SÁNCHEZ-LÓPEZ, RAFAEL CANTÓN
Rev Esp Quimioter 2019; 32 (Suppl. 2): 27-31.
Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa
CELIA CARDOZO, VERÓNICA RICO, DAIANA AGÜERO, ALEX SORIANO
Rev Esp Quimioter 2019; 32 (Suppl. 2): 32-34.
The pharmacodynamic bases of the prescription of antimicrobials
JOSÉ RAMÓN AZANZA PEREA
Rev Esp Quimioter 2019; 32 (Suppl. 2): 35-37.
Practical approach to the management of catheter-related bloodstream infection
Mª LUISA CANTÓN-BULNES, JOSÉ GARNACHO-MONTERO
Rev Esp Quimioter 2019; 32 (Suppl. 2): 38-41.
Stewardship in sepsis
JOSE L. DEL POZO
Rev Esp Quimioter 2019; 32 (Suppl. 2): 42-46.
Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
IVÁN CASTRO, MARIONA TASIAS, EVA CALABUIG, MIGUEL SALAVERT
Rev Esp Quimioter 2019; 32 (Suppl. 2): 47-54.
• Update on the infection of the immunocompromised patient
Update on the management of febrile neutropenia in hematologic patients
FRANCESC ESCRIHUELA-VIDAL. JÚLIA LAPORTE, ADAIA ALBASANZ-PUIG, CARLOTA GUDIOL
Rev Esp Quimioter 2019; 32 (Suppl. 2): 55-58.
Prophylaxis of mould infections
ESTELA MORENO-GARCÍA, MARIANA CHUMBITA, PEDRO PUERTA-ALCALDE, CELIA CARDOZO, CAROLINA GARCIA-VIDAL
Rev Esp Quimioter 2019; 32 (Suppl. 2): 59-62.
Assessment of latent infections in patients receiving biological therapies
MARIO FERNÁNDEZ-RUIZ
Rev Esp Quimioter 2019; 32 (Suppl. 2): 63-68.
Infection in the process of organ donation
OSCAR LEN ABAD
Rev Esp Quimioter 2019; 32 (Suppl. 2): 69-72.
• Evaluation questionnaire
Rev Esp Quimioter 2019; 32 (Suppl. 2): 73-79. [Full-text PDF]
